Abstract Lipid nanoparticles based on solid matrix have emerged as potential drug carriers to improve gastrointestinal (GI) absorption and oral bioavailability of several drugs, especially lipophilic compounds. These formulations may also be used for sustained drug release. Solid lipid nanoparticle (SLN) and the newer generation lipid nanoparticle, nanostructured lipid carrier (NLC), have been studied for their capability as oral drug carriers. Biodegradable, biocompatible, and physiological lipids are generally used to prepare these nanoparticles. Hence, toxicity problems related with the polymeric nanoparticles can be minimized. Furthermore, stability of the formulations might increase than other liquid nano-carriers due to the solid matrix of these lipid nanoparticles. These nanoparticles can be produced by different formulation techniques. Scaling up of the production process from lab scale to industrial scale can be easily achieved. Reasonably high drug encapsulation efficiency of the nanoparticles was documented. Oral absorption and bioavailability of several drugs were improved after oral administration of the drug-loaded SLNs or NLCs. In this review, pros and cons, different formulation and characterization techniques, drug incorporation models, GI absorption and oral bioavailability enhancement mechanisms, stability and storage condition of the formulations, and recent advances in oral delivery of the lipid nanoparticles based on solid matrix will be discussed.
Lipid               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

gastrointestinal (GI)         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_gastrointestinal_tract

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

drugs                         0.9877298489302428^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

industrial                    0.9999563122484508^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Industry              

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

lipophilic                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipophilicity         

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

drug carriers                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_carrier          

physiological                 0.624959862321166^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Physiology            

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

drug encapsulation            0.9999999999819238^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug_encapsulation    

liquid                        0.9999998700818735^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Liquid                

SLN                           0.9999770725263434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Sri_Lanka_Navy        

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

nanostructured                0.6203203880714923^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanotechnology        

drug carriers                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_carrier          

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

absorption                    0.9999999952572125^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

absorption                    0.9999999952572125^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

polymeric                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Polymer               

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

matrix                        0.570713139397933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Composite_material    

drug                          0.9896517921642789^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

matrix                        0.570713139397933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Composite_material    

NLCs                          0.5538625354664546^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/1986_National_League_Championship_Series

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

toxicity                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Toxicity              

absorption                    0.9999999952572125^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

biocompatible                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biocompatibility      

drug                          0.9896517921642789^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

oral drug                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Route_of_administration

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

Biodegradable                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biodegradation        

matrix                        0.570713139397933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Composite_material    

drugs                         0.9877298489302428^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

GI                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_gastrointestinal_tract

carrier                       0.9377451942243763^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Charge_carrier        

